TGF-β signaling in tumor suppression and cancer progression

R Derynck, RJ Akhurst, A Balmain - Nature genetics, 2001 - nature.com
Epithelial and hematopoietic cells have a high turnover and their progenitor cells divide
continuously, making them prime targets for genetic and epigenetic changes that lead to cell …

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

F Chang, LS Steelman, JT Lee… - Leukemia …, 2003 - search.ebscohost.com
Abstract The Ras/Raf/Mitogen-activated protein kinase/ERK kinase (MEK)/extracellular-
signal-regulated kinase (ERK) cascade couples signals from cell surface receptors to …

Histone deacetylases: unique players in shaping the epigenetic histone code

SAM Thiagalingam, KH CHENG, HJ Lee… - Annals of the New …, 2003 - Wiley Online Library
The epigenome is defined by DNA methylation patterns and the associated posttranslational
modifications of histones. This histone code determines the expression status of individual …

TGF-β signaling: positive and negative effects on tumorigenesis

LM Wakefield, AB Roberts - Current opinion in genetics & development, 2002 - Elsevier
TGF-β binding to the cell surface triggers activation of multiple signal transduction pathways
that are connected in intricate ways with each other, and with other response networks …

Clinical development of histone deacetylase inhibitors as anticancer agents

DC Drummond, CO Noble, DB Kirpotin… - Annu. Rev …, 2005 - annualreviews.org
▪ Abstract Acetylation is a key posttranslational modification of many proteins responsible for
regulating critical intracellular pathways. Although histones are the most thoroughly studied …

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines

SE Witta, RM Gemmill, FR Hirsch, CD Coldren… - Cancer research, 2006 - AACR
The epidermal growth factor receptor (EGFR) is overexpressed in the majority of non–small
cell lung cancers (NSCLC). EGFR tyrosine kinase inhibitors, such as gefitinib and erlotinib …

Regulation of TGF-β receptor activity

F Huang, YG Chen - Cell & bioscience, 2012 - Springer
TGF-β signaling regulates diverse cellular processes, including cell proliferation,
differentiation, apoptosis, cell plasticity and migration. Its dysfunctions can result in various …

The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen …

RR Rosato, JA Almenara, S Grant - Cancer research, 2003 - AACR
Abstract Effects of the histone deacetylase (HDAC) inhibitor MS-275 have been examined in
human leukemia and lymphoma cells (U937, HL-60, K562, and Jurkat) as well as in primary …

TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression

B Tang, M Vu, T Booker, SJ Santner… - The Journal of …, 2003 - Am Soc Clin Investig
The TGF-β signaling network plays a complex role in carcinogenesis because it has the
potential to act as either a tumor suppressor or a pro-oncogenic pathway. Currently, it is not …

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma

QC Ryan, D Headlee, M Acharya… - Journal of Clinical …, 2005 - ascopubs.org
Purpose The objective of this study was to define the maximum-tolerated dose (MTD), the
recommended phase II dose, the dose-limiting toxicity, and determine the pharmacokinetic …